Your session is about to expire
← Back to Search
Behavioral Intervention
E-health Letter for Caregiver Well-being (90Second Trial)
N/A
Recruiting
Research Sponsored by IWK Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
90Second Trial Summary
This trial will test if a 90Second Caregiver health letter can help caregivers feel more capable and savour life more, while reducing psychological strain and burden.
Who is the study for?
This trial is for caregivers enrolled in the Caring Forward Trials, who have consented to future studies and data use. They should be experiencing mild distress as indicated by specific psychological assessments (DASS-21 or ZBI-SF).Check my eligibility
What is being tested?
The study tests a '90Second Caregiver health letter' against usual care to see if it improves self-efficacy, quality of life, reduces strain and burden on caregivers, and assesses user engagement with the health letter.See study design
What are the potential side effects?
Since this intervention involves receiving an informational health letter, there are no direct medical side effects. However, there may be varying levels of emotional or psychological impact based on the content's effectiveness.
90Second Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Caregiving self-efficacy
Secondary outcome measures
Caregiver burden
Overall quality of life and general health
Psychological strain
+1 moreOther outcome measures
Usability of the 90Second Caregiver health letter
90Second Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Those receiving the 90Second Caregiver health letterExperimental Treatment1 Intervention
The 90Second Caregiver health letter is a weekly online publication that addresses topics relevant for caregivers. It combines scientifically-valid, evidence-based information with actionable tips to improve caregiver self efficacy and well-being. Participant in this group will receive a 90Second Caregiver health letter every week, via email.
Group II: The usual care control groupActive Control1 Intervention
Participants that are randomized to be in the usual care control group will continue on as participants in the Caring Forward Trials within Cohort Study (i.e. filling out questionnaires every 6-months). Participants will continue to participate in the Caring Forward Study until completion in March 2022.
Find a Location
Who is running the clinical trial?
IWK Health CentreLead Sponsor
125 Previous Clinical Trials
100,143 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have low levels of distress, as shown by your scores on certain tests.You must report feeling more than just a little upset or stressed, as shown by certain test scores.
Research Study Groups:
This trial has the following groups:- Group 1: Those receiving the 90Second Caregiver health letter
- Group 2: The usual care control group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any remaining openings in this clinical investigation?
"Correct. Per clinicaltrials.gov, this medical trial is presently seeking patients to participate in the study and has been since February 17th 2021. It was last updated on May 26th 2023, with a total of 330 participants needed from one center."
Answered by AI
What is the total participant count for this research project?
"Affirmative. Records hosted on clinicaltrials.gov clearly show that this study is actively recruiting, with the initial posting of the trial taking place on February 17 2021 and its most recent edit occurring May 26 2023. The research team needs to enrol 330 volunteers from a single medical centre for participation in their research."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger